These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10493592

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Structural characterization of the feline-immunodeficiency-virus envelope glycoprotein 36 ectodomain for the development of new antivirals.
    Desmaris F, Lemaire D, Ricard-Blum S, Chatrenet B, Forest E.
    Biochem J; 2005 Jul 15; 389(Pt 2):559-67. PubMed ID: 15799719
    [Abstract] [Full Text] [Related]

  • 24. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.
    Fernández-Vidal M, Rojo N, Herrera E, Gómara MJ, Haro I.
    Biophys Chem; 2008 Jan 15; 132(1):55-63. PubMed ID: 17988786
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34.
    Wang LX, Song H, Liu S, Lu H, Jiang S, Ni J, Li H.
    Chembiochem; 2005 Jun 15; 6(6):1068-74. PubMed ID: 15883971
    [Abstract] [Full Text] [Related]

  • 28. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
    Kanyalkar M, Srivastava S, Saran A, Coutinho E.
    J Pept Sci; 2004 Jun 15; 10(6):363-80. PubMed ID: 15214441
    [Abstract] [Full Text] [Related]

  • 29. Membrane-induced conformational change during the activation of HIV-1 gp41.
    Kliger Y, Peisajovich SG, Blumenthal R, Shai Y.
    J Mol Biol; 2000 Aug 25; 301(4):905-14. PubMed ID: 10966795
    [Abstract] [Full Text] [Related]

  • 30. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M.
    Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mutations that destabilize the gp41 core are determinants for stabilizing the simian immunodeficiency virus-CPmac envelope glycoprotein complex.
    Liu J, Wang S, Hoxie JA, LaBranche CC, Lu M.
    J Biol Chem; 2002 Apr 12; 277(15):12891-900. PubMed ID: 11830586
    [Abstract] [Full Text] [Related]

  • 34. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis.
    Lin CH, Chang CC, Cheng SF, Chang DK.
    Electrophoresis; 2008 Aug 12; 29(15):3175-82. PubMed ID: 18633939
    [Abstract] [Full Text] [Related]

  • 35. C-terminal octylation rescues an inactive T20 mutant: implications for the mechanism of HIV/SIMIAN immunodeficiency virus-induced membrane fusion.
    Peisajovich SG, Gallo SA, Blumenthal R, Shai Y.
    J Biol Chem; 2003 Jun 06; 278(23):21012-7. PubMed ID: 12646555
    [Abstract] [Full Text] [Related]

  • 36. Solution structure of the coxsackievirus and adenovirus receptor domain 1.
    Jiang S, Jacobs A, Laue TM, Caffrey M.
    Biochemistry; 2004 Feb 24; 43(7):1847-53. PubMed ID: 14967025
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.